1,4-Bis(trichloromethyl)benzene | CAS:68-36-0
1,4-Bis(trichloromethyl)benzene
- 名称:1,4-双(三氯甲基)苯 | 1,4-Bis(trichloromethyl)benzene
- CAS号:68-36-0
- 别名:
- 分子式:C8H4Cl6
- 分子量:312.83
- EINESC号:200-686-3
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Development and Optimisation of a Multiresidue Method for the Determination of 40 Anthelmintic Compounds in Environmental Water Samples by Solid Phase Extraction (SPE) with LC-MS/MS Detection.Damien Mooney et al.Molecules (Basel, Switzerland), 24(10) (2019-05-28)
A comparison of the metabolism and elimination of benzanilide and salicylanilide in the rat.S C Mitchell et al.Xenobiotica; the fate of foreign compounds in biological systems, 12(2), 93-99 (1982-02-01)
Osteoarthritis of the knee; treatment by local injection of salicylate compounds.K A ROSS et al.British medical journal, 1(5078), 1040-1043 (1958-05-03)
[External therapy of chronic dermatoses].L NOSKO Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin, 13(5), 205-209 (1958-05-01)
[Prevention and therapy of fungus diseases of the foot].W OTTO Medizinische Klinik, 53(51), 2197-2198 (1958-12-19)
Role of a small molecular weight phosphoprotein in the mechanism of action of CI-994 (N-acetyldinaline).S A Rummel et al.International journal of cancer, 62(5), 636-642 (1995-09-04)
In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.Martin Krátký et al.Medicinal chemistry (Shariqah (United Arab Emirates)), 8(4), 732-741 (2012-05-03)
[Treatment of sweaty feet].A STIRN Die Medizinische, 4(8), 348-348 (1959-02-21)
Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.Juana M Férriz et al.Bioorganic & medicinal chemistry, 18(3), 1054-1061 (2010-01-12)
Photosynthesis-Inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates.Ales Imramovsky et al.Bioorganic & medicinal chemistry letters, 21(15), 4564-4567 (2011-07-05)
Identification of 14-3-3zeta by chemical affinity with salicylanilide inhibitors of interleukin-12p40 production.Jim P Boyce et al.Bioconjugate chemistry, 19(9), 1775-1784 (2008-09-04)
A closer study of peak distortions in supercritical fluid chromatography as generated by the injection.Martin Enmark et al.Journal of chromatography. A, 1400, 131-139 (2015-05-24)
Isocitrate lyase: a potential target for anti-tubercular drugs.Rohit Sharma et al.Recent patents on inflammation & allergy drug discovery, 7(2), 114-123 (2013-03-20)
Salicylanilide acetates: synthesis and antibacterial evaluation.Jarmila Vinsova et al.Molecules (Basel, Switzerland), 12(1), 1-12 (2007-08-19)
In vitro antibacterial and antifungal activity of salicylanilide benzoates.Martin Krátký et al.TheScientificWorldJournal, 2012, 290628-290628 (2012-06-06)
Harmaline-resistant mutant of Methanothermobacter thermautotrophicus with a lesion in Na(+)/H(+) antiport.Monika Vidová et al.General physiology and biophysics, 30 Spec No, S54-S60 (2011-10-01)
Surveillance. SAC C vs disease surveillance report. Cases of poisoning in Scottish cattle and sheep. The Veterinary record, 169(24), 628-631 (2012-01-25)
Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking.Ales Imramovsky et al.Molecules (Basel, Switzerland), 17(9), 10142-10158 (2012-08-28)
[New alo-, nitro-, and alonitro- derivatives of o-hydroxybenzanilide and their antimicrobial activity].E Piscopo et al.Bollettino della Societa italiana di biologia sperimentale, 58(20), 1309-1314 (1982-10-30)
Salicylanilides: selective inhibitors of interleukin-12p40 production.Michael E Brown et al.Bioorganic & medicinal chemistry, 16(18), 8760-8764 (2008-08-22)
Assessment of the solid-state composition of an active salicylanilide compound by FT-Raman spectroscopy.B De Spiegeleer et al.Journal of pharmaceutical and biomedical analysis, 44(1), 254-257 (2007-03-14)
Experimental salicylate poisoning: observations on the effects of carbonic anhydrase inhibitor and bicarbonate.S A KAPLAN et al.Pediatrics, 21(5), 762-770 (1958-05-01)
Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.Ronald Domalaon et al.The Journal of antibiotics, 72(8), 605-616 (2019-04-28)
Observations on the treatment of rheumatic fever with salicylate, ACTH and cortisone. II. Combined salicylate and corticoid therapy and attempts at rebound suppression.E E FISCHEL et al.Arthritis and rheumatism, 1(4), 351-366 (1958-08-01)
Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives.Yuya Ohtsuki et al.Biochemical and biophysical research communications, 509(1), 287-293 (2018-12-28)
Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human In Vitro Systems.Peter R Bradshaw et al.Scientific reports, 8(1), 2405-2405 (2018-02-07)
Salicylate intoxication treated with artificial kidney.R O BURNS et al.The West Virginia medical journal, 54(6), 198-199 (1958-06-01)
[Extranit therapy of peripheral circulatory disorders].O PRIESSNITZ Munchener medizinische Wochenschrift (1950), 100(18), 729-730 (1958-05-02)
Application of reactive salicylanilide to viscose fabrics as antibacterial and antifungus finishing.A Atef El-Sayed et al.International journal of biological macromolecules, 50(1), 273-276 (2011-11-26)
Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.Ales Imramovský et al.Bioorganic & medicinal chemistry letters, 19(2), 348-351 (2008-12-17)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!